Press releases

  1. Blueprint Genetics expands in North America by building a new CLIA/CAP NGS facility in Seattle
  2. DelSiTech Ltd Receives Significant Funding for Developing Long-Acting Injectables for contraceptives and HIV antivirals development by the Bill & Melinda Gates Foundation
  3. Helsinki Biobank and Fimmic Introduce a Unique One Access Service for Biomedical Research
  4. Faron Pharmaceuticals Admission to AIM and first day of dealings £10 million fundraise to progress Phase III clinical trial
  5. Faron Enters Agreement with Selexis SA to Progress Development of Novel Cancer Immunotherapy Clevegen
  6. Fimmic closes investment round to digitalize cancer diagnostics
  7. Faron Pharmaceuticals Oy Intention to Float on AIM
  8. Innomedica to open new office in Switzerland
  9. FIT Biotech’s Initial Public Offering Completed Successfully
  10. BioFinland prize to Biovian Oy
  11. Forendo Pharma announces the US licensing of fispemifene to Apricus Biosciences targeting urological conditions in men
  12. Oncos Therapeutics Demonstrates Systemic, Tumor-specific Immune Response by Local Administration of its Lead Product ONCOS-102
  13. Promising new treatment for life threatening acute respiratory distress syndrome (ARDS)
  14. KU Leuven and FIT Biotech enter into a worldwide license and collaboration agreement for the development of novel immunotherapeutics
  15. Neste Jacobs and Roal Sign a Contract to Expand Enzyme Production Plant
  16. BioFinland 2013 prize to Glykos Finland Ltd
  17. Culminatum Innovation and Diaceutics Collaborate to Provide Expert Training to Leading Finnish Researchers on Commercializing Biomarkers for Personalized Medicine
  18. Innomedica and CMC Biologics into strategic agreement for Japan market
  19. Faron reports positive headline data from FPCLI001 clinical study with FP- 1201 in acute lung injuries
  20. Faron and Maruishi Sign Traumakine-program License Agreement
  21. Rentschler to manufacture Faron product Traumakine®
  22. Change of management in Novamass Ltd
  23. Innomedica Expands in UK – Dr Jim Phillips Joins the Team

FINNISH BIOINDUSTRIES FIB
Eteläranta 10, FI-00131 Helsinki
+358 50 404 5166